A2108112
Btk inhibitor 1 R enantiomer , 98% , 1022150-12-4
CAS NO.:1022150-12-4
Empirical Formula: C22H22N6O
Molecular Weight: 386.45
MDL number: MFCD20482137
EINECS: 200-001-8
| Pack Size | Price | Stock | Quantity |
| 250MG | RMB70.40 | In Stock |
|
| 1G | RMB204.80 | In Stock |
|
| 5g | RMB853.60 | In Stock |
|
| 25g | RMB3187.20 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | 133-136oC |
| Boiling point: | 626.3±55.0 °C(Predicted) |
| Density | 1.39±0.1 g/cm3(Predicted) |
| storage temp. | under inert gas (nitrogen or Argon) at 2–8 °C |
| solubility | DMSO (Slightly), Methanol (Slightly) |
| pka | 9.00±0.10(Predicted) |
| form | Solid |
| color | White to Pale Yellow |
| optical activity | -9.6828°(C=0.5249g/100ml MEOH) |
| InChIKey | GPSQYTDPBDNDGI-MRXNPFEDSA-N |
| SMILES | C1=NC(N)=C2C(C3=CC=C(OC4=CC=CC=C4)C=C3)=NN([C@@H]3CCCNC3)C2=N1 |
Description and Uses
IBT6A is a Btk kinase inhibitor. This compound is a precurser for the manufacture of ibrutinib.
(R)-3-(4-Phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine is an intermediate used to prepare pyrazolo-pyrimidine compounds as inhibitors of Bruton''s tyrosine kinase. It is also an intermediate for Ibrutinib (I124970) derivatives.
Safety
| Symbol(GHS) | ![]() GHS07 |
| Signal word | Warning |
| Hazard statements | H315-H319 |
| Precautionary statements | P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313 |






![3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine](https://img.chemicalbook.com/CAS/20150408/GIF/330786-24-8.gif)
